_version_ 1784882656129843200
author Thalambedu, Nishanth
Ogunsesan, Yetunde
Sethi, Jaskirat
Hussain, Munawwar
Yarlagadda, Lakshmi
Gundarlapalli, Sravani
Hadidi, Samer Al
Thanendrarajan, Sharmilan
Zangari, Maurizio
Spencer, Horace
Bailey, Clyde
Shaughnessy, John
Zhan, Fenghuang
Rico, Juan Carlos
van Rhee, Frits
Schinke, Carolina
author_facet Thalambedu, Nishanth
Ogunsesan, Yetunde
Sethi, Jaskirat
Hussain, Munawwar
Yarlagadda, Lakshmi
Gundarlapalli, Sravani
Hadidi, Samer Al
Thanendrarajan, Sharmilan
Zangari, Maurizio
Spencer, Horace
Bailey, Clyde
Shaughnessy, John
Zhan, Fenghuang
Rico, Juan Carlos
van Rhee, Frits
Schinke, Carolina
author_sort Thalambedu, Nishanth
collection PubMed
description
format Online
Article
Text
id pubmed-9899531
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-98995312023-02-06 Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant Thalambedu, Nishanth Ogunsesan, Yetunde Sethi, Jaskirat Hussain, Munawwar Yarlagadda, Lakshmi Gundarlapalli, Sravani Hadidi, Samer Al Thanendrarajan, Sharmilan Zangari, Maurizio Spencer, Horace Bailey, Clyde Shaughnessy, John Zhan, Fenghuang Rico, Juan Carlos van Rhee, Frits Schinke, Carolina Transplant Cell Ther Poster Session: Myeloma - Clinical American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2023-02 2023-02-06 /pmc/articles/PMC9899531/ http://dx.doi.org/10.1016/S2666-6367(23)00602-4 Text en Copyright © 2023 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Session: Myeloma - Clinical
Thalambedu, Nishanth
Ogunsesan, Yetunde
Sethi, Jaskirat
Hussain, Munawwar
Yarlagadda, Lakshmi
Gundarlapalli, Sravani
Hadidi, Samer Al
Thanendrarajan, Sharmilan
Zangari, Maurizio
Spencer, Horace
Bailey, Clyde
Shaughnessy, John
Zhan, Fenghuang
Rico, Juan Carlos
van Rhee, Frits
Schinke, Carolina
Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
title Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
title_full Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
title_fullStr Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
title_full_unstemmed Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
title_short Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
title_sort immunogenicity of covid-19 vaccine among multiple myeloma patients post autologous stem cell transplant
topic Poster Session: Myeloma - Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899531/
http://dx.doi.org/10.1016/S2666-6367(23)00602-4
work_keys_str_mv AT thalambedunishanth immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT ogunsesanyetunde immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT sethijaskirat immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT hussainmunawwar immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT yarlagaddalakshmi immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT gundarlapallisravani immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT hadidisameral immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT thanendrarajansharmilan immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT zangarimaurizio immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT spencerhorace immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT baileyclyde immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT shaughnessyjohn immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT zhanfenghuang immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT ricojuancarlos immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT vanrheefrits immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant
AT schinkecarolina immunogenicityofcovid19vaccineamongmultiplemyelomapatientspostautologousstemcelltransplant